PI3K is dysfunctional in a wide range of cancers and inhibition of PI3K has proven effective to mitigate the carcinogenic upregulation of PI3K that leads to uncontrolled cellular growth (Yang et al., 2019). This evidence concerns the gene PIK3CD and cancer.